Milestone Pharmaceuticals announced that CARDAMYST (etripamil) nasal spray converted about two-thirds of patients with recurrent paroxysmal supraventricular tachycardia (PSVT) after prior catheter ablation to normal heart rhythm within 30 minutes, based on a subgroup analysis from the Phase 3 RAPID trial. This FDA-approved nasal spray offers a self-administered treatment option for patients experiencing PSVT episodes outside emergency settings, addressing a gap for those with recurrent symptoms post-ablation. The data will be presented at the American Heart Association Scientific Sessions 2026, supporting CARDAMYST as a safe and effective therapy for managing PSVT episodes.
CARDAMYST nasal spray's effectiveness in converting recurrent PSVT to normal heart rhythm is highlighted alongside Pluang's health sector market data. For readers following health stocks, here is Pluang's market snapshot as of Nov 02, 2026 19:21 WIB: out of 150 priced US health-sector stocks, 82 rose and 47 fell. Notable movers include HRTX at USD 0.29 (+4.43%), MMED at USD 17.74 (-2.95%), and MRVI at USD 8.03 (+2.82%).
The global bio-based construction polymer market, valued at $18.2 billion in 2025, is projected to grow to $35 billion by 2033 at an 8.3% CAGR. Growth is fueled by rising demand for sustainable building materials that reduce greenhouse gas emissions ...
Annual Over-the-Air (OTA) software updates for software-defined vehicles (SDVs) are projected to reach over 2 billion globally by 2035, up from 546 million in 2025, driven by rising SDV sales and advanced vehicle software platforms. Level 3 and above...
Fram Wind Solutions AS, a joint venture partly owned by BW Offshore, secured a NOK 1.94 billion grant from Enova to develop a floating offshore wind project featuring two 18.5 MW turbines, the largest globally, with a combined capacity of 37 MW. The ...
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
